Welcome to our dedicated page for Iqvia Hldgs SEC filings (Ticker: IQV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how IQVIA turns billions of clinical data points into revenue can feel like decoding a medical registry. Key figures on contract research backlogs, technology licensing, and goodwill impairment are scattered across dense reports, and keeping up with IQVIA insider trading Form 4 transactions adds another layer of complexity. Investors who type 鈥�IQVIA SEC filings explained simply鈥� need more than raw documents鈥攖hey need answers. Stock Titan鈥檚 AI reads every line the moment it hits EDGAR and highlights what matters.
Whether you鈥檙e hunting for the latest IQVIA quarterly earnings report 10-Q filing, comparing cash-flow trends inside an IQVIA annual report 10-K simplified, or needing IQVIA Form 4 insider transactions real-time, our platform delivers. We pair line-by-line machine learning with human-trained models, turning raw data into plain-English takeaways. Drill into revenue by segment, R&D capitalization, or debt covenants in seconds鈥�understanding IQVIA SEC documents with AI becomes straightforward. Each page also links to thorough IQVIA earnings report filing analysis prepared by our research desk, so you can move from numbers to narrative without opening a spreadsheet.
Looking beyond quarterly results, Stock Titan monitors every event that could move the share price. Receive instant alerts when IQVIA 8-K material events explained鈥攖hink acquisitions, data breaches, or leadership changes鈥攁re posted. Explore IQVIA executive stock transactions Form 4 to gauge management sentiment, and review the IQVIA proxy statement executive compensation section to see how performance metrics align with pay. With real-time updates, AI-powered summaries, and historical search across all forms, you鈥檒l spend less time digging and more time deciding.
IQVIA Holdings Inc. (IQV) filed a Form 4 showing that Senior Vice President & Corporate Controller Keriann Cherofsky sold 549 common shares on 07/23/2025 at $191.53 per share, a transaction valued at roughly $105k. After the sale, her direct ownership stands at 2,910 shares; no derivative securities were involved.
The disposition reduced her direct stake by about 16% (549 of ~3,459 prior shares). While small relative to IQV鈥檚 market capitalization and daily trading volume, insider sales can be perceived as a modestly bearish signal because executives possess superior insight into company prospects. No accompanying purchases, option exercises, or material company events were reported in this filing.
IQVIA Holdings Inc. (IQV) 鈥� Form 144 filing discloses a proposed insider sale of common stock under Rule 144.
- Securities offered: 5,800 common shares
- Estimated market value: $1,102,262.16 (鈮� $190 per share)
- Broker: Morgan Stanley Smith Barney LLC, New York
- Planned sale date: 23 Jul 2025 on the NYSE
- Total shares outstanding: 170 million; proposed sale equals <0.01% of float
- Source of shares: Stock Appreciation Rights acquired on 23 Jul 2025; consideration paid in cash
The filer states no material non-public adverse information is known. No other sales were made in the past three months. Given the small size relative to IQVIA鈥檚 float and the absence of accompanying operational data, the notice is unlikely to affect valuation or liquidity materially.
FAQ
What is the current stock price of Iqvia Hldgs (IQV)?
What is the market cap of Iqvia Hldgs (IQV)?
